miDiagnostics
Series D in 2024
miDiagnostics is a Belgian company focused on creating innovative testing solutions that allow individuals to perform blood analyses independently. The company is developing a novel chip-based technology that enables the rapid detection of various biomarkers from minimal blood samples, such as those obtained from a finger prick. This technology integrates a nanofluidic processor with a compact reader, facilitating the measurement of cells, proteins, nucleic acids, and small molecules. By providing disposable tests that are easy to use and offer built-in connectivity, miDiagnostics aims to enhance diagnostic capabilities for both patients and clinicians, making lab-quality testing accessible anytime and anywhere.
Lizy is a car leasing company based in Brussels, Belgium, founded in 2018 by entrepreneurs Sam Heymans and Vincent Castus. The company operates an online platform designed to simplify the car leasing process for small and medium-sized enterprises (SMEs) and professionals. Lizy offers transparent all-in pricing, flexible leasing contracts, and a selection of high-quality used cars that are readily available. By focusing on a quick and inexpensive leasing experience, Lizy enables clients to conveniently order vehicles online and have them delivered directly to their location, thereby streamlining the often cumbersome leasing process.
Itineris
Venture Round in 2022
Itineris develops and implements UMAX, a cloud-based CIS and CRM platform for utilities that uses workflow automation and AI to manage meter-to-cash processes, revenue collection, assets, rates, conservation, marketing, and campaigns, while improving customer engagement and operational efficiency. The platform is built on Microsoft Dynamics 365 and delivered as a service in the Azure cloud, helping water and energy utilities align IT systems with business processes and address regulatory, infrastructural, and operational challenges. Founded in 2003, Itineris has implemented solutions for utilities in Europe and the United States, including De Watergroep, Eneco, SSE, Flogas, and public sector clients such as the New York Department of Environmental Protection and the Boston Water and Sewer Commission.
SOPHiA GENETICS
Series E in 2019
SOPHiA GENETICS is a healthcare technology company specializing in data-driven medicine. It offers the SOPHiA DDMâ„¢ Platform, a cloud-based SaaS solution that analyzes complex multimodal datasets from various diagnostic modalities to generate insights. With over 780 global clients, including hospitals, laboratories, and biopharma institutions across three continents, the company aims to make data-driven medicine the standard of care in healthcare and life sciences research.
SOPHiA GENETICS
Series D in 2017
SOPHiA GENETICS is a healthcare technology company specializing in data-driven medicine. It offers the SOPHiA DDMâ„¢ Platform, a cloud-based SaaS solution that analyzes complex multimodal datasets from various diagnostic modalities to generate insights. With over 780 global clients, including hospitals, laboratories, and biopharma institutions across three continents, the company aims to make data-driven medicine the standard of care in healthcare and life sciences research.